[HTML][HTML] Gout epidemiology and comorbidities
JA Singh, A Gaffo - Seminars in arthritis and rheumatism, 2020 - Elsevier
Objective To review the epidemiology of gout and associated comorbidities. Methods We
review the key published studies of the epidemiology of gout and associated comorbidities …
review the key published studies of the epidemiology of gout and associated comorbidities …
2016 updated EULAR evidence-based recommendations for the management of gout
Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …
have become available since the publication of the first European League Against …
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed.
New data on imaging and clinical diagnosis have become available since the first EULAR …
New data on imaging and clinical diagnosis have become available since the first EULAR …
[HTML][HTML] Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний»
ИИ Дедов, МВ Шестакова… - Ожирение и …, 2021 - cyberleninka.ru
Клинические рекомендации уже давно вошли в число рабочих инструментов
современного врача, помогая ему быстро ориентироваться в наиболее эффективных …
современного врача, помогая ему быстро ориентироваться в наиболее эффективных …
Global epidemiology of gout: prevalence, incidence and risk factors
Gout is a crystal-deposition disease that results from chronic elevation of uric acid levels
above the saturation point for monosodium urate (MSU) crystal formation. Initial presentation …
above the saturation point for monosodium urate (MSU) crystal formation. Initial presentation …
[HTML][HTML] The British Society for Rheumatology guideline for the management of gout
M Hui, A Carr, S Cameron, G Davenport… - …, 2017 - academic.oup.com
Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
Epidemiology of gout
E Roddy, HK Choi - Rheumatic Disease Clinics, 2014 - rheumatic.theclinics.com
Gout is a crystal deposition disease that arises when supersaturation of body tissues with
urate occurs, leading to the formation of monosodium urate (MSU) crystals in and around …
urate occurs, leading to the formation of monosodium urate (MSU) crystals in and around …
Gout. Epidemiology of gout
E Roddy, M Doherty - Arthritis research & therapy, 2010 - Springer
Gout is the most prevalent form of inflammatory arthropathy. Several studies suggest that its
prevalence and incidence have risen in recent decades. Numerous risk factors for the …
prevalence and incidence have risen in recent decades. Numerous risk factors for the …
Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis
N Dalbeth, A Phipps-Green, C Frampton… - Annals of the …, 2018 - ard.bmj.com
Objectives To provide estimates of the cumulative incidence of gout according to baseline
serum urate. Methods Using individual participant data from four publicly available cohorts …
serum urate. Methods Using individual participant data from four publicly available cohorts …